Expected earnings - Xilio Therapeutics Inc.
Source: US Earnings Reports
Xilio Therapeutics Inc. (XLO) is expected to report $-0.08 for Q2 2025
Xilio Therapeutics Inc.
NASDAQ: XLO
XLO Trading
-2.15% G/L:
$0.5187 Last:
158,741 Volume:
$0.5113 Open:
XLO Latest News
March 02, 2026 08:00:00 am
Xilio Therapeutics to Present at the Leerink Partners Global Healthcare Conference
XLO Stock Data
$36,573,414
29,954,402
2.14%
13
N/A
Biotechnology & Life Sciences
Healthcare
US
Waltham
